MEOH Stock Analysis: Methanex | NASDAQ
Chemicals | NASDAQ, USA | Market Cap: 4.759m USD | 12M Return: 56.5% | CA59151K1084 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 41.4M
EPS Trend: 18.3%
Qual. Beats: 0
Rev. Trend: 26.6%
Qual. Beats: -1
Warnings
No concerns identified
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Methanex Corporation (NASDAQ: MEOH) is a Canadian-headquartered commodity chemicals producer that manufactures and sells methanol and ammonia to chemical and petrochemical customers across Asia Pacific, North America, Europe, and South America. Incorporated in 1968 and based in Vancouver, the company supplements its production operations with owned and leased in-region storage and terminal facilities, supporting global distribution to its downstream customers.
The company operates within the Materials sector (Commodity Chemicals sub-industry). Methanol is a key industrial feedstock used to produce formaldehyde, acetic acid, olefins, and various fuels and fuel additives, while ammonia is primarily consumed by the agricultural fertilizer industry. Methanexs vertically integrated production-to-terminal model is designed to deliver consistent supply to international customers, a structural feature of large-scale methanol producers.
- Methanol spot prices rise on Chinese MTO demand
- Natural gas feedstock costs pressure production margins
- Geismar plant restart adds North American supply
| Net Income: 88.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -0.02 > 1.0 |
| NWC/Revenue: 20.34% < 20% (prev 23.49%; Δ -3.15% < -1%) |
| CFO/TA 0.11 > 3% & CFO 797.5m > Net Income 88.4m |
| Net Debt (3.48b) to EBITDA (1.01b): 3.45 < 3 |
| Current Ratio: 2.07 > 1.5 & < 3 |
| Outstanding Shares: last quarter (77.5m) vs 12m ago 14.26% < -2% |
| Gross Margin: 28.58% > 18% (prev 24.79%; Δ 3.79% > 0.5%) |
| Asset Turnover: 57.10% > 50% (prev 46.03%; Δ 11.07% > 0%) |
| Interest Coverage Ratio: 2.34 > 6 (EBIT TTM 529.7m / Interest Expense TTM 226.6m) |
| A: 0.12 (Total Current Assets 1.67b - Total Current Liabilities 807.5m) / Total Assets 7.17b |
| B: 0.25 (Retained Earnings 1.81b / Total Assets 7.17b) |
| C: 0.07 (EBIT TTM 529.7m / Avg Total Assets 7.47b) |
| D: 0.60 (Book Value of Equity 2.56b / Total Liabilities 4.30b) |
| Altman-Z'' = 2.72 = A |
| DSRI: 1.08 (Receivables 622.5m/485.4m, Revenue 4.27b/3.58b) |
| GMI: 0.87 (GM 24.79% / 28.58%) |
| AQI: 0.68 (AQ_t 0.06 / AQ_t-1 0.10) |
| SGI: 1.19 (Revenue 4.27b / 3.58b) |
| TATA: -0.10 (NI 88.4m - CFO 797.5m) / TA 7.17b) |
| Beneish M = -3.15 (Cap -4..+1) = AA |
As of September 20, 2026, the stock is trading at USD 60.97 with a total of 1,065,328 shares traded. Over the past week, the price has changed by -2.80%, over one month by +6.24%, over three months by +14.97% and over the past year by +56.45%.
Current recommended Stop Loss: 56.40 (which is 7.5% or 2 ATR below the current price).
Methanex has received a consensus analysts rating of 4.22. Therefore, it is recommended to buy MEOH.
- StrongBuy: 4
- Buy: 3
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 70 | 14.8% |
P/E Trailing = 73.2262
P/E Forward = 11.4416
P/S = 1.1157
P/B = 1.9441
P/EG = 0.1982
Revenue TTM = 4.27b USD
EBIT TTM = 529.7m USD
EBITDA TTM = 1.01b USD
Long Term Debt = 2.39b USD (from longTermDebt, last quarter)
Short Term Debt = 142.6m USD (from shortTermDebt, last quarter)
Debt = 3.86b USD (from shortLongTermDebtTotal, last quarter) + Leases 732.8m
Net Debt = 3.48b USD (calculated: Debt 3.86b - CCE 382.4m)
Enterprise Value = 8.24b USD (4.76b + Debt 3.86b - CCE 382.4m)
Interest Coverage Ratio = 2.34 (Ebit TTM 529.7m / Interest Expense TTM 226.6m)
EV/FCF = 11.14x (Enterprise Value 8.24b / FCF TTM 739.5m)
FCF Yield = 8.98% (FCF TTM 739.5m / Enterprise Value 8.24b)
FCF Margin = 17.34% (FCF TTM 739.5m / Revenue TTM 4.27b)
Net Margin = 2.07% (Net Income TTM 88.4m / Revenue TTM 4.27b)
Gross Margin = 28.58% ((Revenue TTM 4.27b - Cost of Revenue TTM 3.05b) / Revenue TTM)
Gross Margin QoQ = 45.73% (prev 20.87%)
Tobins Q-Ratio = 1.15 (Enterprise Value 8.24b / Total Assets 7.17b)
Interest Expense / Debt = 5.87% (Interest Expense 226.6m / Debt 3.86b)
Taxrate = 41.80% (126.7m / 303.1m)
NOPAT = 308.3m (EBIT 529.7m * (1 - 41.80%))
Current Ratio = 2.07 (Total Current Assets 1.67b / Total Current Liabilities 807.5m)
Debt / Equity = 1.51 (Debt 3.86b / totalStockholderEquity, last quarter 2.56b)
Debt / EBITDA = 3.45 (Net Debt 3.48b / EBITDA 1.01b)
Debt / FCF = 4.71 (Net Debt 3.48b / FCF TTM 739.5m)
Total Stockholder Equity = 2.50b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.18% (Net Income 88.4m / Total Assets 7.17b)
RoE = 3.54% (Net Income TTM 88.4m / Total Stockholder Equity 2.50b)
RoCE = 10.85% (EBIT 529.7m / Capital Employed (Equity 2.50b + L.T.Debt 2.39b))
RoIC = 4.90% (NOPAT 308.3m / Invested Capital 6.29b)
WACC = 6.38% (E(4.76b)/V(8.62b) * Re(8.78%) + D(3.86b)/V(8.62b) * Rd(5.87%) * (1-Tc(0.42)))
Discount Rate = 8.78% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 86.11 | Cagr: 6.32%
[DCF] Terminal Value 74.29% ; FCFF base≈765.0m ; Y1≈717.0m ; Y5≈661.9m
[DCF] Fair Price = 90.14 (EV 10.5b - Net Debt 3.48b = Equity 6.97b / Shares 77.4m; r=8.35% [WACC [floored]]; 5y FCF grow -7.93% → 2.50% )
EPS Correlation: 18.32 | EPS CAGR: 9.04% | SUE: -0.27 | # QB: 0
Revenue Correlation: 26.61 | Revenue CAGR: 1.45% | SUE: -1.27 | # QB: -1
EPS current Quarter (2026-09-30): EPS=2.79 | Chg30d=-3.83% | Revisions=-25% | Analysts=9
EPS current Year (2026-12-31): EPS=9.02 | Chg30d=-0.50% | Revisions=-25% | GrowthEPS=+344.4% | GrowthRev=+35.7%
EPS next Year (2027-12-31): EPS=5.77 | Chg30d=+3.91% | Revisions=-25% | GrowthEPS=-36.0% | GrowthRev=-17.8%
[Analyst] Revisions Ratio: -50% (up=0, down=3)